Latest Articles

Subject

Research Article
Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple SclerosisA Mendelian Randomization Study
Marijne Vandebergh, Bénédicte Dubois, An Goris

April 07, 2022
Research Article
Transcription Factor c-Maf Promotes Immunoregulation of Programmed Cell Death 1–Expressed CD8⁺ T Cells in Multiple Sclerosis
Shusuke Koto, Norio Chihara, Ritsu Akatani, et al.

April 05, 2022
Article
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models
Michael Dietrich, Christina Hecker, Elodie Martin, et al.

March 30, 2022
Article
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
Katerina Karagiorgou, Maria Dandoulaki, Renato Mantegazza, et al.

March 29, 2022
Research Article
MRI Characteristics of Autoimmune Encephalitis With Autoantibodies to GABAA ReceptorA Case Series
Bo Deng, Mengfei Cai, Yue Qiu, et al.

March 25, 2022
Research Article
Cryptococcal Meningitis Reported With Fingolimod TreatmentCase Series
Maurizio Del Poeta, Brian J. Ward, Benjamin Greenberg, et al.

March 22, 2022
Research Article
Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies
Luise Appeltshauser, Julia Messinger, Katharina Starz, et al.

March 21, 2022
Clinical/Scientific Note
Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 AntibodiesCase Report
Antoine Pegat, Emilien Delmont, Juliette Svahn, et al.

March 21, 2022
Research Article
Dynamics of Retinal Vessel Loss After Acute Optic Neuritis in Patients With Relapsing Multiple Sclerosis
Lilian Aly, Christina Noll, Rebecca Wicklein, et al.

March 17, 2022
Research Article
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
Doriana Landi, Alfonso Grimaldi, Francesca Bovis, et al.

March 10, 2022

Pages